Using Photovoice to shine light on health inequities among youths of color during the pandemic

Youth movements for social justice are growing across the U.S. and worldwide, tackling important issues from climate change, to racial justice, to education access and gun control. In the realm of health care, youth participation can lead to greater patient understanding, engagement in services and enhanced trust in services. It can also promote patient and community empowerment. Recognizing the benefits […]

Continue reading »

Novel wearable sensor can detect two key biomarkers of infection in sweat

University of Texas at Dallas bioengineers in collaboration with EnLiSense LLC have designed a wearable sensor that can detect two key biomarkers of infection in human sweat, a significant step toward making it possible for users to receive early warnings of infections such as COVID-19 and influenza. The Erik Jonsson School of Engineering and Computer Science researchers' study, published online […]

Continue reading »

Analysis of more than 82,000 autistic children’s health care usage data finds disparities

A new analysis of data collected from more than 82,000 autistic children across seven years reveals significant differences in their health care utilization according to sex, race and ethnicity. Results of the study led by Assistant Professor Amber Angell and its implications were recently published online in Research in Autism Spectrum Disorders. Previous research has shown that autistic children and […]

Continue reading »

Moderna Plans to Build Vaccine Facility in Quebec

(Reuters) – Moderna Inc said on Friday it plans to build an mRNA vaccine manufacturing facility in Quebec province as part of the COVID-19 vaccine maker’s 10-year partnership with the Canadian government to better prepare for future pandemics. The construction of the facility, which would be able to produce up to 100 million mRNA respiratory vaccine doses annually, is expected […]

Continue reading »

Upadacitinib Earns FDA Approval for Ankylosing Spondylitis

The US Food and Drug Administration has approved upadacitinib (Rinvoq) as an oral treatment for active ankylosing spondylitis in adults, its manufacturer AbbVie announced April 29. Upadacitinib, a selective and reversible Janus kinase inhibitor, is the second drug in its class to be FDA-approved for ankylosing spondylitis, after tofacitinib (Xeljanz) in December. Upadacitinib is now indicated for patients with active […]

Continue reading »
1 466 467 468 469 470 1,322